Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)
| 0.3629 Data as of 3:59pm ET |  -0.0271 / -6.95%Today’s Change | 0.28 Today|||52-Week Range 0.81 | +17.06% Year-to-Date |
Latest RNN News | Press Releases
No recent news for Rexahn Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.39 |
| Day’s range | 0.36 - 0.40 |
| Volume | 1,117,795 |
| Average volume (3 months) | 496,255 |
| Market cap | $46.6M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | -50.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGDXResponse Genetics In... | 0.00 | 0.00% |
| HSKAHeska Corp | -0.11 | -1.40% |
| DMPIDelMar Pharmaceutica... | +0.15 | +7.50% |
| BGMDBG Medicine Inc | -0.07 | -3.91% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientist Chang Ho Ahn, PhD |
President & Chief Operating Officer Rakesh Soni, MBA |
Corporate headquarters Rockville, Maryland |
Forecasts
